111 related articles for article (PubMed ID: 38335659)
1. Unveiling the oncogenic role of CLDN11-secreting fibroblasts in gastric cancer peritoneal metastasis through single-cell sequencing and experimental approaches.
Liu K; Wang Y; Shao W; Tang C; Zhao S; Xu J; Xu P; Cheng Q; Huang S; Ji P; Qiu S
Int Immunopharmacol; 2024 Mar; 129():111647. PubMed ID: 38335659
[TBL] [Abstract][Full Text] [Related]
2. Crosstalk between cancer-associated fibroblasts and immune cells in peritoneal metastasis: inhibition in the migration of M2 macrophages and mast cells by Tranilast.
Nakamura Y; Kinoshita J; Yamaguchi T; Aoki T; Saito H; Hamabe-Horiike T; Harada S; Nomura S; Inaki N; Fushida S
Gastric Cancer; 2022 May; 25(3):515-526. PubMed ID: 34997450
[TBL] [Abstract][Full Text] [Related]
3. CCL21 and CLDN11 Are Key Driving Factors of Lymph Node Metastasis in Gastric Cancer.
Yang S; Dong D; Bao X; Lu R; Cheng P; Zhu S; Yang G
Cancer Control; 2024; 31():10732748241238616. PubMed ID: 38553809
[TBL] [Abstract][Full Text] [Related]
4. BGN/FAP/STAT3 positive feedback loop mediated mutual interaction between tumor cells and mesothelial cells contributes to peritoneal metastasis of gastric cancer.
Wu H; Xiang Z; Huang G; He Q; Song J; Dou R; Yang C; Wang S; Xiong B
Int J Biol Sci; 2023; 19(2):465-483. PubMed ID: 36632455
[TBL] [Abstract][Full Text] [Related]
5. lncRNA PCAT18 inhibits proliferation, migration and invasion of gastric cancer cells through miR-135b suppression to promote CLDN11 expression.
Zhang XZ; Mao HL; Zhang SJ; Sun L; Zhang WJ; Chen QZ; Wang L; Liu HC
Life Sci; 2020 May; 249():117478. PubMed ID: 32119960
[TBL] [Abstract][Full Text] [Related]
6. Adipocytes contribute to tumor progression and invasion of peritoneal metastasis by interacting with gastric cancer cells as cancer associated fibroblasts.
Hamabe-Horiike T; Harada SI; Yoshida K; Kinoshita J; Yamaguchi T; Fushida S
Cancer Rep (Hoboken); 2023 Jan; 6(1):e1647. PubMed ID: 35691615
[TBL] [Abstract][Full Text] [Related]
7. Established fibrous peritoneal metastasis in an immunocompetent mouse model similar to clinical immune microenvironment of gastric cancer.
Fujimori D; Kinoshita J; Yamaguchi T; Nakamura Y; Gunjigake K; Ohama T; Sato K; Yamamoto M; Tsukamoto T; Nomura S; Ohta T; Fushida S
BMC Cancer; 2020 Oct; 20(1):1014. PubMed ID: 33081727
[TBL] [Abstract][Full Text] [Related]
8. Exosomal NNMT from peritoneum lavage fluid promotes peritoneal metastasis in gastric cancer.
Zhu AK; Shan YQ; Zhang J; Liu XC; Ying RC; Kong WC
Kaohsiung J Med Sci; 2021 Apr; 37(4):305-313. PubMed ID: 33508890
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-autophagy axis induces VEGFA by peritoneal mesothelial cells to promote gastric cancer peritoneal metastasis through an integrin α5-fibronectin pathway.
Wang X; Che X; Yu Y; Cheng Y; Bai M; Yang Z; Guo Q; Xie X; Li D; Guo M; Hou K; Guo W; Qu X; Cao L
J Exp Clin Cancer Res; 2020 Oct; 39(1):221. PubMed ID: 33081836
[TBL] [Abstract][Full Text] [Related]
10. CXCR7 as a chemokine receptor for SDF-1 promotes gastric cancer progression via MAPK pathways.
Shi A; Shi H; Dong L; Xu S; Jia M; Guo X; Wang T
Scand J Gastroenterol; 2017; 52(6-7):745-753. PubMed ID: 28281844
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of CXCR7 Is a Novel Prognostic Indicator in Gastric Cancer.
Nambara S; Iguchi T; Oki E; Tan P; Maehara Y; Mimori K
Dig Surg; 2017; 34(4):312-318. PubMed ID: 27941339
[TBL] [Abstract][Full Text] [Related]
12. CXCR7/CXCL12 axis is involved in lymph node and liver metastasis of gastric carcinoma.
Xin Q; Zhang N; Yu HB; Zhang Q; Cui YF; Zhang CS; Ma Z; Yang Y; Liu W
World J Gastroenterol; 2017 May; 23(17):3053-3065. PubMed ID: 28533662
[TBL] [Abstract][Full Text] [Related]
13. Silencing of claudin-11 is associated with increased invasiveness of gastric cancer cells.
Agarwal R; Mori Y; Cheng Y; Jin Z; Olaru AV; Hamilton JP; David S; Selaru FM; Yang J; Abraham JM; Montgomery E; Morin PJ; Meltzer SJ
PLoS One; 2009 Nov; 4(11):e8002. PubMed ID: 19956721
[TBL] [Abstract][Full Text] [Related]
14. Extracellular vesicle derived miR-544 downregulates expression of tumor suppressor promyelocytic leukemia zinc finger resulting in increased peritoneal metastasis in gastric cancer.
Kong W; Liu X; Yin G; Zheng S; Zhu A; Yu P; Shan Y; Ying R; Zhang J
Aging (Albany NY); 2020 Nov; 12(23):24009-24022. PubMed ID: 33221764
[TBL] [Abstract][Full Text] [Related]
15. Exosomal hsa-let-7g-3p and hsa-miR-10395-3p derived from peritoneal lavage predict peritoneal metastasis and the efficacy of neoadjuvant intraperitoneal and systemic chemotherapy in patients with gastric cancer.
Luo J; Jiang L; He C; Shi M; Yang ZY; Shi M; Lu S; Li C; Zhang J; Yan M; Zhu ZG; Yan C
Gastric Cancer; 2023 May; 26(3):364-378. PubMed ID: 36738390
[TBL] [Abstract][Full Text] [Related]
16. Proteomic profiling of gastric cancer with peritoneal metastasis identifies a protein signature associated with immune microenvironment and patient outcome.
Chen Y; Cai G; Jiang J; He C; Chen Y; Ding Y; Lu J; Zhao W; Yang Y; Zhang Y; Wu G; Wang H; Zhou Z; Teng L
Gastric Cancer; 2023 Jul; 26(4):504-516. PubMed ID: 36930369
[TBL] [Abstract][Full Text] [Related]
17. LPS-induced CXCR7 expression promotes gastric Cancer proliferation and migration via the TLR4/MD-2 pathway.
Li N; Xu H; Ou Y; Feng Z; Zhang Q; Zhu Q; Cai Z
Diagn Pathol; 2019 Jan; 14(1):3. PubMed ID: 30636642
[TBL] [Abstract][Full Text] [Related]
18. Rab27b, a Regulator of Exosome Secretion, Is Associated With Peritoneal Metastases in Gastric Cancer.
Nambara S; Masuda T; Hirose K; Hu Q; Tobo T; Ozato Y; Kurashige J; Hiraki Y; Hisamatsu Y; Iguchi T; Sugimachi K; Oki E; Yoshizumi T; Mimori K
Cancer Genomics Proteomics; 2023; 20(1):30-39. PubMed ID: 36581340
[TBL] [Abstract][Full Text] [Related]
19. Exosomal miR-21-5p derived from gastric cancer promotes peritoneal metastasis via mesothelial-to-mesenchymal transition.
Li Q; Li B; Li Q; Wei S; He Z; Huang X; Wang L; Xia Y; Xu Z; Li Z; Wang W; Yang L; Zhang D; Xu Z
Cell Death Dis; 2018 Aug; 9(9):854. PubMed ID: 30154401
[TBL] [Abstract][Full Text] [Related]
20. Paracrine activin B-NF-κB signaling shapes an inflammatory tumor microenvironment in gastric cancer via fibroblast reprogramming.
Jin Y; Cai Q; Wang L; Ji J; Sun Y; Jiang J; Wang C; Wu J; Zhang B; Zhao L; Qi F; Yu B; Zhang J
J Exp Clin Cancer Res; 2023 Oct; 42(1):269. PubMed ID: 37858201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
